Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2026-06-12 12:28:50 ET · period of report 2026-06-12 · accession 0001055919-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 12:28 | 2026-06-12 | SMMT | DUGGAN ROBERT W | Co-CEO, Dir, 10% | P - Purchase | $13.12 | +3.81M | 573.88M | +0.7% | +$49.99M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-12 | P | A | 3,810,000 | $13.12 | 573,883,879 | D | — | — |